United States · FDA National Drug Code directory
buspirone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65841-784_0ea86a43-52f7-4fad-acda-a4625f4280a2
- Product NDC
- 65841-784
- Form
- TABLET
- Composition / generic term
- buspirone hydrochloride
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140503
- Source listing expiry
- 20271231
Source-listed ingredients
- BUSPIRONE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (65841-784-05) · 65841-784-05
- 1000 TABLET in 1 BOTTLE (65841-784-10) · 65841-784-10
- 60 TABLET in 1 BOTTLE (65841-784-14) · 65841-784-14
- 100 BLISTER PACK in 1 CARTON (65841-784-77) / 1 TABLET in 1 BLISTER PACK (65841-784-30) · 65841-784-77
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →